J Clin Oncol 2020 Jan 1
PD-1 Blockade in Advanced Adrenocortical Carcinoma.   

Related Questions

The phase 2 trial of pembrolizumab in JCO 2019 showed efficacy, and I have patients preferring to avoid chemotherapy.